Diamyd Medical announced that 100 patients are now enrolled in the company’s US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA and more sites are to be added. The study will include 320 children and adolescents between 10 and 20 years of age, recently diagnosed with type 1 diabetes. To date more...

Using stem cells from a patient’s own body fat, scientists have been able to reverse symptoms of multiple sclerosis , reports Telegraph.  MS, an autoimmune disease, is caused by the destruction of myelin, a fatty protective sheath surrounding the body’s central nervous system.  These preliminary findings, based on three...

A new treatment for type 1 diabetes could be a step closer thanks to a EU grant of €10.9 million, according to a Media-Newswire press release. Two University of Bristol academics are part of a group of 14 leading researchers who have received the award.  Professor Polly Bingley and Dr Colin Dayan will collaborate with researchers from...

Japanese scientists say they’ve identified the cause of early rejection of transplanted pancreatic islet cells used in treating type 1 diabetes. According to a UPI report, researchers at the Riken Institute and Fukuoka University said their discovery sets the stage for development of treatment technique which could be four times...

Diabetes UK reported today that scientists in Cambridge have shown that an ‘artificial pancreas’ can be used to regulate blood glucose in children with type 1 diabetes. A JDRF funded study found that combining a real-time sensor measuring glucose levels with a pump that delivers insulin can boost overnight blood glucose control.The...

JDRF announced that research financed by JDRF may hold a key component for a possible type 1 diabetes cure. The researchers at the Salk Institute for Biological Studies in California found that a hormone responsible for the body’s stress response is also linked to the growth of insulin-producing cells in the pancreas. The researchers...

Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, announced it plans to file the Diamyd® diabetes vaccine for market approval in 2011. The European Phase III study with Diamyd® has been fully recruited meaning that the first results...

The Juvenile Diabetes Research Foundation announced it had teamed up Animas Corporation to develop an automated system to help people with type 1 diabetes better control their disease – the first step on the path to what would be among the most revolutionary advancements in treating type 1 diabetes: the development of an artificial...

A new study reported by Science Daily found that Individuals with the highest caloric intake were more likely to develop vision-threatening retinopathy. In addition, high sodium intake at the initial examination was associated with the development of macular edema. The researchers assessed 469 African American patients with type 1 diabetes...

Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, reports today that the United States Food and Drug Administration has approved the experimental use of Diamyd® vaccine in children as young as 3 years of age in the TrialNet GAD study,...